The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
Autor: | Alexis E. Te, Malek Meskawi, Kevin C. Zorn, Lesa D. Deonarine, Vincent Misrai, Bilal Chughtai, Ramy Goueli, Dominique Thomas, Pierre-Alain Hueber |
---|---|
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
Population 030232 urology & nephrology Urology lcsh:RC870-923 03 medical and health sciences 0302 clinical medicine Interquartile range Lower urinary tract symptoms Prostate Medicine education education.field_of_study Benign prostatic hyperplasia business.industry Urinary retention lcsh:Diseases of the genitourinary system. Urology medicine.disease Small prostate Catheter GreenLight XPS medicine.anatomical_structure Photovaporization of the prostate 030220 oncology & carcinogenesis Original Article International Prostate Symptom Score medicine.symptom business Body mass index |
Zdroj: | Asian Journal of Urology, Vol 6, Iss 4, Pp 353-358 (2019) Asian Journal of Urology |
ISSN: | 2214-3882 |
DOI: | 10.1016/j.ajur.2019.01.006 |
Popis: | Objective: Our objective was to characterize the safety and efficacy of the 180 W XPS-GreenLight laser in men with lower urinary tract symptoms secondary to a small volume benign prostatic hyperplasia (BPH). Methods: A retrospective analysis was performed for all patients who underwent 180 W XPS-laser photoselective vaporization of the prostate (PVP) vaporization of the prostate between 2012 and 2016 at two-tertiary medical centers. Data collection included baseline comorbidities, disease-specific quality of life scores, maximum urinary flow rate (Qmax), postvoid residual (PVR), complications, prostate volume and prostate-specific antigen (PSA). The secondary endpoints were the incidence of intraoperative and postoperative adverse events. Complications were stratified using the Clavien-Dindo grading system up to 90 days after surgery. Results: Mean age of men was 67.8 years old, with a mean body mass index of 29.7 kg/m2. Mean prostate volume as measured by transrectal ultrasound was 29 mL. Anticoagulation use was 47% and urinary retention with catheter at time of surgery was 17%. Mean hospital stay and catheter time were 0.5 days. Median follow-up time was 6 months with the longest duration of follow-up being 22.5 months (interquartile range, 3–22.5 months). The International Prostate Symptom Score improved from 22.8 ± 7.0 at baseline to 10.7 ± 7.4 (p |
Databáze: | OpenAIRE |
Externí odkaz: |